# Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation

> **NCT05309382** · — · COMPLETED · sponsor: **Natera, Inc.** · enrollment: 147 (actual)

## Conditions studied

- Heart Transplant

## Interventions

- **DIAGNOSTIC_TEST:** Prospera

## Key facts

- **NCT ID:** NCT05309382
- **Lead sponsor:** Natera, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-12
- **Primary completion:** 2024-10-02
- **Final completion:** 2024-10-02
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2024-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05309382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05309382, "Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05309382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*